INTI / Inhibitor Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Inhibitor Therapeutics, Inc.
US ˙ OTCPK

Deler fremragende 172,573,545 shares
Insideraktier447.585.264 shares
Total Insiders25
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )

2539 out of 11314

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000 %( )

2525 out of 11237

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Inhibitor Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Black Robe Capital LLC 10% Owner - [10%] 40.202.114 40.202.114
James D Causey Director - [D] 1.000 1.000
Stefan Cross Director - [D] 0 0
Peter C Einselen 3.000
Richard J Freer Chief Executive Officer, Director, 10% Owner - [D] [O] [10%] 7.485.141 7.485.141
Hasara Garrison J. CFO and Treasurer - [O] 3.972.544 3.972.544
HedgePath, LLC 10% Owner - [10%] 79.627.069 79.627.069
Michael Allen Jerman Director - [D] 80.411 80.411
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Gerald P Krueger Director - [D] 0 0
Magrab E. Brendan Director - [D] 65.000 65.000
James A Mcnulty 10% Owner - [10%] 1.946.135 1.946.135
Robert Daniel Martin Director - [D] 116.000 116.000
Pharma Group Ltd Mayne 10% Owner - [10%] 204.083.227 204.083.227
Pharma Ventures Pty Ltd Mayne Director, 10% Owner - [D] [10%] 204.083.227 204.083.227
Francis E Jr Odonnell See Remarks, Director, 10% Owner - [D] [O] [10%] 85.627.069 85.627.069
Ronald E Osman Director, 10% Owner - [D] [10%] 23.554.985 23.554.985
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Richard Dana Ono Director - [D] 453.000 453.000
Debra Peattie 580.646
Ronald E Osman Irrevocable Trust III 10% Owner - [10%] 23.489.985 23.554.985
Samuel P Jr Sears Director - [D] 1.279.543 1.279.543
Tpb 2012 Llc 10% Owner - [10%] 28.616.250 28.616.250
Nicholas J Virca President and CEO - [O] 8.727.519 8.727.519
Niraj Vasisht 0
Watson W. Mark Director - [D] 1.054.100 1.054.100
Michelle Yanez Director - [D] 896.271 896.271

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i INTI / Inhibitor Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2019-12-12 Watson W. Mark 500 0,0619 500 0,0619 31 180 0.1035 22 72,50
2019-12-02 Hasara Garrison J. 13.500 0,0700 13.500 0,0700 945
2017-12-19 Mayne Pharma Ventures Pty Ltd 600.000 162.660,0000 600.000 162.660,0000 97.596.000.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INTI / Inhibitor Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i INTI / Inhibitor Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2018-08-30 Hasara Garrison J. 100.000 0,2700 100.000 0,2700 27.000 145 0.0410 -22.900 -84,81
2017-06-30 HedgePath, LLC 2.500.000 2.500.000
2016-06-15 HedgePath, LLC 2.560.000 2.560.000
2016-06-15 ODONNELL FRANCIS E JR 2.560.000 2.560.000
2015-09-10 HedgePath, LLC 20.000.000 20.000.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INTI / Inhibitor Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-04-10 2025-04-01 4 Vasisht Niraj INTI Common Stock A - Award D 50.000
2025-04-07 2025-04-01 4 Yanez Michelle INTI Common Stock A - Award D 50.000 896.271
2025-04-07 2025-04-01 4 SEARS SAMUEL P JR INTI Common Stock A - Award D 50.000 1.279.543
2025-04-07 2025-04-01 4 OSMAN RONALD E See Footnotes INTI Common Stock A - Award I 50.000 23.554.985
2025-04-07 2025-04-01 4 Jerman Michael Allen INTI Common Stock A - Award D 50.000 80.411
2025-02-19 2024-12-02 5 MCNULTY JAMES A INTI Common Stock G - Gift D 1.000.000 1.946.135
2025-02-19 2024-12-02 5 Yanez Michelle INTI Common Stock G - Gift D 250.000 1.146.271
2024-05-16 2024-04-01 4 Jerman Michael Allen INTI Common Stock A - Award D 50.000 80.411
2024-05-16 2024-04-01 4 OSMAN RONALD E Seefootnote INTI Common Stock A - Award I 50.000 23.564.985
2024-05-16 2024-04-01 4 SEARS SAMUEL P JR INTI Common Stock A - Award D 50.000 1.129.543
2024-05-16 2024-04-01 4 Yanez Michelle INTI Common Stock A - Award D 50.000 896.271
2023-08-29 2023-08-11 4 OSMAN RONALD E INTI Common Stock A - Award D 25.000 23.514.985
2023-08-29 3 Ronald E Osman Irrevocable Trust III INTI Common Stock D 23.489.985
2023-05-22 3 Donovan James Joseph III INTI Common Stock D 349.500
2023-05-22 3 Donovan James Joseph III INTI Common Stock I 27.917.250
2023-05-17 2023-05-05 4 MCNULTY JAMES A INTI Common Stock J - Other I 20.101.057 26.101.057
2023-05-17 2023-05-05 4 MCNULTY JAMES A INTI Common Stock J - Other D 398.135 946.135
2023-05-17 2023-05-05 4 MCNULTY JAMES A INTI Common Stock J - Other I -79.627.069 0
2023-05-17 3 MCNULTY JAMES A INTI Common Stock D 20.101.057
2023-05-17 2023-05-05 4 Yanez Michelle INTI Common Stock J - Other D 796.271 800.673
2022-12-22 3 SEARS SAMUEL P JR INTI Common Stock D 969.096
2022-12-22 3 ODONNELL FRANCIS E JR See Footnotes INTI Common Stock I 85.627.069
2022-12-22 3 Yanez Michelle INTI Common Stock D 4.402
2022-12-22 3 MCNULTY JAMES A See Footnotes INTI Common Stock I 85.627.069
2022-12-22 3 MCNULTY JAMES A INTI Common Stock D 548.000
2021-01-19 2021-01-15 4 Mayne Pharma Ventures Pty Ltd INTI Common Stock J - Other D 2.240.488 204.083.227
2020-12-28 2020-12-22 4 Watson W. Mark INTI Common Stock Option A - Award D 0,03 1.306.452 1.306.452
2020-12-28 2020-12-22 4 Martin Robert Daniel INTI Common Stock Option A - Award D 0,03 754.839 754.839
2020-12-28 2020-12-22 4 VIRCA NICHOLAS J INTI Common Stock Option A - Award D 0,03 125.000 125.000
2020-12-28 2020-12-22 4 Peattie Debra INTI Common Stock Option A - Award D 0,03 580.646 580.646
2020-12-28 2020-12-22 4 Hasara Garrison J. INTI Common Stock Option A - Award D 0,03 125.000 125.000
2020-12-28 2020-12-22 4 Ono Richard Dana INTI Common Stock Option A - Award D 0,03 754.839 754.839
2020-09-21 2020-09-17 4 VIRCA NICHOLAS J INTI Common Stock Option A - Award D 0,05 100.000 100.000
2020-09-21 2020-09-17 4 Hasara Garrison J. INTI Common Stock Option A - Award D 0,05 100.000 100.000
2020-07-20 2020-07-15 4 Mayne Pharma Ventures Pty Ltd INTI Common Stock J - Other D 3.189.688 201.842.739
2020-03-24 2020-03-20 4 Watson W. Mark INTI Common Stock Option A - Award D 0,05 1.500.000 1.500.000
2020-03-24 2020-03-20 4 Martin Robert Daniel INTI Common Stock Option A - Award D 0,05 1.000.000 1.000.000
2020-03-24 2020-03-20 4 Peattie Debra INTI Common Stock Option A - Award D 0,05 1.000.000 1.000.000
2020-03-24 2020-03-20 4 Ono Richard Dana INTI Common Stock Option A - Award D 0,05 1.000.000 1.000.000
2020-02-10 2019-12-12 5 Watson W. Mark INTI Common Stock P - Purchase D 0,0619 500 0 1.054.100
2019-12-16 2019-12-12 4 Peattie Debra INTI Common Stock Option A - Award D 0,05 210.000 210.000
2019-12-02 2019-12-02 4 Hasara Garrison J. INTI Common Stock P - Purchase D 0,0700 13.500 1 3.972.544
2019-06-10 2019-06-03 4 Watson W. Mark HPPI Common Stock Option A - Award D 0,07 25.000 25.000
2019-02-05 2019-02-03 4 MAGRAB E. BRENDAN HPPI Common Stock Options A - Award D 0,08 986.842 986.842
2019-02-05 2019-02-03 4 Watson W. Mark HPPI Common Stock Option A - Award D 0,08 657.895 657.895
2019-02-05 2019-02-03 4 Martin Robert Daniel HPPI Common Stock Option A - Award D 0,08 657.895 657.895
2019-02-05 2019-02-03 4 Ono Richard Dana HPPI Common Stock Option A - Award D 0,08 657.895 657.895
2019-01-24 2019-01-15 4 Mayne Pharma Ventures Pty Ltd HPPI Common Stock J - Other D 362.121 198.653.051
2018-12-26 2018-12-20 4 MAGRAB E. BRENDAN HPPI Common Stock A - Award D 0,0800 65.000 5 65.000
2018-12-26 2018-12-20 4 Martin Robert Daniel HPPI Common Stock A - Award D 0,0800 60.000 5 116.000
2018-12-19 2018-07-15 4 Mayne Pharma Ventures Pty Ltd HPPI Common Stock J - Other D 184.798 198.290.930
2018-08-31 2018-08-30 4 Hasara Garrison J. HPPI Common Stock S - Sale D 0,2700 -100.000 -27 3.959.044
2018-07-06 2018-07-05 4 Mayne Pharma Ventures Pty Ltd HPPI Series B Warrants to Purchase Common Stock P - Purchase D 0,28 1.739.131 1.739.131
2018-07-06 2018-07-05 4 Mayne Pharma Ventures Pty Ltd HPPI Series A Warrants to Purchase Common Stock P - Purchase D 0,23 1.739.131 1.739.131
2018-07-06 2018-07-05 4 Mayne Pharma Ventures Pty Ltd HPPI Series B Convertible Preferred Stock P - Purchase D 2.318.841 5.797.102
2018-03-15 2018-03-13 4 Martin Robert Daniel HPPI Common Stock Option A - Award D 0,27 56.000 56.000
2018-03-15 2018-03-13 4 Martin Robert Daniel HPPI Common Stock Option A - Award D 0,27 253.000 253.000
2018-03-15 2018-03-13 4 MAGRAB E. BRENDAN HPPI Common Stock Options A - Award D 0,27 345.000 345.000
2018-03-15 2018-03-13 4 Ono Richard Dana HPPI Common Stock Option A - Award D 0,27 56.000 56.000
2018-03-15 2018-03-13 4 Ono Richard Dana HPPI Common Stock Option A - Award D 0,27 253.000 253.000
2018-03-15 2018-03-13 4 VIRCA NICHOLAS J HPPI Common Stock Option A - Award D 0,27 310.000 310.000
2018-03-15 2018-03-13 4 Hasara Garrison J. HPPI Common Stock Option A - Award D 0,27 260.000 260.000
2018-03-15 2018-03-13 4 Watson W. Mark HPPI Common Stock Option A - Award D 0,27 76.000 76.000
2018-03-15 2018-03-13 4 Watson W. Mark HPPI Common Stock Option A - Award D 0,27 253.000 253.000
2018-02-12 2017-12-19 4 Cross Stefan HPPI Common Stock P - Purchase D 162.660,0000 -600.000 -97.596.000 0
2018-02-12 2017-12-19 4 Mayne Pharma Ventures Pty Ltd HPPI Common Stock P - Purchase D 162.660,0000 600.000 97.596.000 198.106.132
2018-01-11 2018-01-10 4 Mayne Pharma Ventures Pty Ltd HPPI Series A Warrants to Purchase Common Stock P - Purchase D 0,23 2.608.696 2.608.696
2018-01-11 2018-01-10 4 Mayne Pharma Ventures Pty Ltd HPPI Series B Warrants to Purchase Common Stock P - Purchase D 0,28 2.608.696 2.608.696
2018-01-11 2018-01-10 4 Mayne Pharma Ventures Pty Ltd HPPI Series B Convertible Preferred Stock P - Purchase D 3.478.261 3.478.261
2017-07-19 2017-05-04 4 MAGRAB E. BRENDAN HPPI Restricted Stock Units A - Award D 65.000 65.000
2017-07-19 2017-05-04 4 Martin Robert Daniel HPPI Restricted Stock Units A - Award D 60.000 60.000
2017-07-12 2017-06-30 4 HedgePath, LLC HPPI Common Stock, $.0001 par value per share S - Sale D -2.500.000 79.627.069
2017-03-10 2017-03-08 4 Hasara Garrison J. HPPI Restricted Stock Units M - Exercise D -3.500.000 0
2017-03-10 2017-03-08 4 Hasara Garrison J. HPPI Restricted Stock Units M - Exercise D -3.500.000 0
2017-03-10 2017-03-08 4 Hasara Garrison J. HPPI Common Stock F - Taxes D 0,3400 -1.470.478 -500 4.059.044
2017-03-10 2017-03-08 4 Hasara Garrison J. HPPI Common Stock F - Taxes D 0,3400 -1.470.478 -500 4.059.044
2017-03-10 2017-03-08 4 Hasara Garrison J. HPPI Common Stock M - Exercise D 3.500.000 5.529.522
2017-03-10 2017-03-08 4 Hasara Garrison J. HPPI Common Stock M - Exercise D 3.500.000 5.529.522
2017-03-10 2017-03-08 4 Watson W. Mark HPPI Restricted Stock Units M - Exercise D -200.000 0
2017-03-10 2017-03-08 4 Watson W. Mark HPPI Restricted Stock Units M - Exercise D -400.000 0
2017-03-10 2017-03-08 4 Watson W. Mark HPPI Restricted Stock Units M - Exercise D -300.000 0
2017-03-10 2017-03-08 4 Watson W. Mark HPPI Common Stock F - Taxes D 0,3400 -79.200 -27 553.600
2017-03-10 2017-03-08 4 Watson W. Mark HPPI Common Stock M - Exercise D 200.000 632.800
2017-03-10 2017-03-08 4 Watson W. Mark HPPI Common Stock F - Taxes D 0,3400 -158.400 -54 432.800
2017-03-10 2017-03-08 4 Watson W. Mark HPPI Common Stock M - Exercise D 400.000 591.200
2017-03-10 2017-03-08 4 Watson W. Mark HPPI Common Stock F - Taxes D 0,3400 -118.800 -40 191.200
2017-03-10 2017-03-08 4 Watson W. Mark HPPI Common Stock M - Exercise D 300.000 310.000
2017-03-10 2017-03-08 4 Ono Richard Dana HPPI Restricted Stock Units M - Exercise D -150.000 0
2017-03-10 2017-03-08 4 Ono Richard Dana HPPI Restricted Stock Units M - Exercise D -300.000 0
2017-03-10 2017-03-08 4 Ono Richard Dana HPPI Restricted Stock Units M - Exercise D -300.000 0
2017-03-10 2017-03-08 4 Ono Richard Dana HPPI Common Stock F - Taxes D 0,3400 -59.400 -20 453.000
2017-03-10 2017-03-08 4 Ono Richard Dana HPPI Common Stock M - Exercise D 150.000 512.400
2017-03-10 2017-03-08 4 Ono Richard Dana HPPI Common Stock F - Taxes D 0,3400 -118.800 -40 362.400
2017-03-10 2017-03-08 4 Ono Richard Dana HPPI Common Stock F - Taxes D 0,3400 -118.800 -40 362.400
2017-03-10 2017-03-08 4 Ono Richard Dana HPPI Common Stock M - Exercise D 300.000 481.200
2017-03-10 2017-03-08 4 Ono Richard Dana HPPI Common Stock M - Exercise D 300.000 481.200
2017-03-10 2017-03-08 4 Cross Stefan HPPI Restricted Stock Units M - Exercise D -300.000 0
2017-03-10 2017-03-08 4 Cross Stefan HPPI Restricted Stock Units M - Exercise D -300.000 0
2017-03-10 2017-03-08 4 Cross Stefan HPPI Common Stock M - Exercise D 300.000 600.000
2017-03-10 2017-03-08 4 Cross Stefan HPPI Common Stock M - Exercise D 300.000 600.000
2017-03-10 2017-03-08 4 VIRCA NICHOLAS J HPPI Restricted Stock Units M - Exercise D -15.041.738 0
2017-03-10 2017-03-08 4 VIRCA NICHOLAS J HPPI Common Stock F - Taxes D 0,3400 -6.314.219 -2.147 8.727.519
2017-03-10 2017-03-08 4 VIRCA NICHOLAS J HPPI Common Stock M - Exercise D 15.041.738 15.041.738
2016-11-15 2016-11-15 4 Mayne Pharma Ventures Pty Ltd HPPI Warrant to Purchase Common Stock X - Other D 0,12 -4.860.000 23.504.236
2016-11-15 2016-11-15 4 Mayne Pharma Ventures Pty Ltd HPPI Warrant to Purchase Common Stock X - Other D 0,08 -333 0
2016-11-15 2016-11-15 4 Mayne Pharma Ventures Pty Ltd HPPI Warrant to Purchase Common Stock X - Other D 0,09 -4.750.569 0
2016-11-15 2016-11-15 4 Mayne Pharma Ventures Pty Ltd HPPI Common Stock X - Other D 4.860.000 197.506.132
2016-11-15 2016-11-15 4 Mayne Pharma Ventures Pty Ltd HPPI Common Stock X - Other D 333 192.646.132
2016-11-15 2016-11-15 4 Mayne Pharma Ventures Pty Ltd HPPI Common Stock X - Other D 4.750.569 192.645.799
2016-11-07 2016-11-04 4 Mayne Pharma Ventures Pty Ltd HPPI Warrant to Purchase Common Stock X - Other D 0,08 -33.333.000 333
2016-11-07 2016-11-04 4 Mayne Pharma Ventures Pty Ltd HPPI Warrant to Purchase Common Stock X - Other D 0,09 -5.500.000 4.750.569
2016-11-07 2016-11-04 4 Mayne Pharma Ventures Pty Ltd HPPI Common Stock X - Other D 33.333.000 187.895.230
2016-11-07 2016-11-04 4 Mayne Pharma Ventures Pty Ltd HPPI Common Stock X - Other D 5.500.000 154.562.230
2016-07-06 2016-07-01 4 SEARS SAMUEL P JR HPPI Options to Purchase Common Stock A - Award D 0,24 150.000 150.000
2016-07-06 2016-07-01 4 SEARS SAMUEL P JR HPPI Restricted Stock Units A - Award D 150.000 150.000
2016-07-06 2016-07-01 4 Ono Richard Dana HPPI Restricted Stock Units A - Award D 150.000 150.000
2016-07-06 2016-07-01 4 Ono Richard Dana HPPI Options to Purchase Common Stock A - Award D 0,24 150.000 150.000
2016-07-06 2016-07-01 4 Watson W. Mark HPPI Restricted Stock Units A - Award D 200.000 200.000
2016-07-06 2016-07-01 4 Watson W. Mark HPPI Options to Purchase Common Stock A - Award D 0,24 200.000 200.000
2016-06-20 2016-06-15 4/A ODONNELL FRANCIS E JR By Hopkins Capital Group II, LLC HPPI Common Stock, $.0001 par value per share P - Purchase I 2.560.000 16.560.000
2016-06-20 2016-06-15 4 HedgePath, LLC HPPI Common Stock, $.0001 par value per share S - Sale D -2.560.000 82.127.069
2016-06-17 2016-06-15 4 ODONNELL FRANCIS E JR By Hopkins Capital Group II, LLC HPPI Common Stock, $.0001 par value per share S - Sale I -2.560.000 11.440.000
2016-06-08 2016-06-06 4 ODONNELL FRANCIS E JR By Hopkins Capital Group II, LLC HPPI Common Stock, $.0001 par value per share J - Other I -6.000.000 14.000.000
2016-05-27 2016-05-25 4 Mayne Pharma Group Ltd Footnote HPPI* Warrant to Purchase Common Stock A - Award I 0,01 28.364.236 71.948.138
2016-05-27 2016-05-25 4 Mayne Pharma Group Ltd Footnote HPPI* Common Stock A - Award I 27.885.000 149.062.230
2015-09-14 2015-09-10 4 ODONNELL FRANCIS E JR By Hopkins Capital Group II, LLC HPPI Common Stock, $.0001 par value per share P - Purchase I 20.000.000 20.000.000
2015-09-14 2015-09-10 4 HedgePath, LLC HPPI Common Stock, $.0001 par value per share S - Sale D -20.000.000 84.687.069
2015-09-14 2014-08-14 4 HedgePath, LLC HPPI Common Stock, $.0001 par value per share C - Conversion D 82.156.842 104.687.069
2015-08-18 2015-08-14 4 Cross Stefan HPPI Restricted Stock Units A - Award D 300.000 300.000
2015-08-18 2015-08-14 4 Ono Richard Dana HPPI Restricted Stock Units A - Award D 300.000 300.000
2015-08-18 2015-08-14 4 SEARS SAMUEL P JR HPPI Restricted Stock Units A - Award D 300.000 300.000
2015-08-18 2015-08-14 4 Watson W. Mark HPPI Restricted Stock Units A - Award D 400.000 400.000
2015-05-19 2015-05-15 4 Mayne Pharma Group Ltd Footnote HPPI Warrant to Purchase Common Stock A - Award I 0,08 33.333.333 43.583.902
2015-05-19 2015-05-15 4 Mayne Pharma Group Ltd Footnote HPPI Common Stock A - Award I 33.333.333 121.177.230
2015-02-06 2014-07-18 5 VIRCA NICHOLAS J HPPI Restricted Stock Units A - Award D 15.041.738 15.041.738
2015-02-06 2014-08-06 5 Hasara Garrison J. HPPI Restricted Stock Units A - Award D 3.500.000 3.500.000
2015-02-06 2014-08-06 5 Hasara Garrison J. HPPI Restricted Stock Units A - Award D 3.500.000 3.500.000
2015-02-06 2014-07-18 5 Cross Stefan HPPI Restricted Stock Units A - Award D 300.000 300.000
2015-02-06 2014-07-18 5 SEARS SAMUEL P JR HPPI Restricted Stock Units A - Award D 300.000 300.000
2015-02-06 2014-07-18 5 Ono Richard Dana HPPI Restricted Stock Units A - Award D 300.000 300.000
2015-02-06 2014-07-18 5 Watson W. Mark HPPI Restricted Stock Units A - Award D 300.000 300.000
2014-09-09 2014-09-08 4 Watson W. Mark HPPI Common Stock P - Purchase D 0,1300 10.000 1 10.000
2014-07-09 2014-06-24 4 ODONNELL FRANCIS E JR By Trust HPPI Series A Convertible Preferred Stock J - Other I 18.984 64.034
2014-07-09 2014-06-24 4 ODONNELL FRANCIS E JR By Hedgepath LLC HPPI Series A Convertible Preferred Stock J - Other I 4.012 13.532
2014-07-09 2014-06-24 4 ODONNELL FRANCIS E JR By Trust HPPI Warrant to purchase Common Stock J - Other I 0,88 2.716.401 2.716.401
2014-07-09 2014-06-24 4 ODONNELL FRANCIS E JR By Hedgepath LLC HPPI Warrant to purchase Common Stock J - Other I 0,88 574.032 574.032
2014-07-09 2014-06-24 4 ODONNELL FRANCIS E JR By Trust HPPI Common Stock, $.0001 par value per share J - Other I 670.510 670.510
2014-07-09 2014-06-24 4 ODONNELL FRANCIS E JR By Hedgepath LLC HPPI Common Stock, $.0001 par value per share J - Other I 141.693 141.693
2014-07-09 2014-06-24 4 ODONNELL FRANCIS E JR By Trust HPPI Common Stock, $.0001 par value per share J - Other I 0,0750 5.300.000 398 5.970.510
2014-07-09 2014-06-24 4 ODONNELL FRANCIS E JR By Hedgepath LLC HPPI Common Stock, $.0001 par value per share J - Other I 0,0750 1.120.000 84 1.261.693
2014-07-09 2014-06-24 4 HedgePath, LLC HPPI Series A Convertible Preferred Stock A - Award D 71.636 241.637
2014-07-09 2014-06-24 4 HedgePath, LLC HPPI Warrant to purchase Common Stock A - Award D 0,88 10.250.569 10.250.569
2014-07-09 2014-06-24 4 HedgePath, LLC HPPI Common Stock, $.0001 par value per share A - Award D 2.530.227 2.530.227
2014-07-09 2014-06-24 4 HedgePath, LLC HPPI Common Stock, $.0001 par value per share A - Award D 0,0750 20.000.000 1.500 22.530.227
2014-06-26 2014-06-24 4 Mayne Pharma Ventures Pty Ltd CBTEQ Common Stock Purchase Warrant A - Award D 0,09 1 1
2014-06-26 2014-06-24 4 Mayne Pharma Ventures Pty Ltd CBTEQ Series A Convertible Preferred Stock A - Award D 258.363 258.363
2013-08-16 2013-08-13 4 ODONNELL FRANCIS E JR By Trust CBTEQ Series A Convertible Preferred Stock A - Award I 45.050 45.050
2013-08-16 2013-08-13 4 ODONNELL FRANCIS E JR By HedgePath, LLC CBTEQ Series A Convertible Preferred Stock A - Award I 9.520 9.520
2013-08-16 2013-08-13 4 HedgePath, LLC CBTEQ Series A Convertible Preferred Stock A - Award D 170.001 170.001
2013-04-19 2013-04-12 4 FREER RICHARD J CBTEQ Common Stock J - Other D 0,0457 2.846.715 130 7.485.141
2013-04-19 2013-04-12 4 SEARS SAMUEL P JR CBTEQ Common Stock J - Other D 0,0457 372.263 17 1.016.096
2012-09-07 2012-08-22 4 FREER RICHARD J CBTEQ Common Stock J - Other D 0,0200 2.025.000 40 4.638.426
2005-03-22 2005-03-22 4 CAUSEY JAMES D CBTE Common Stock A - Award D 4,2390 1.000 4 1.000
2005-01-06 2005-01-03 4 EINSELEN PETER C CBTE Options A - Award D 6,00 6,0000 3.000 18 3.000
2005-01-04 2005-01-03 4 Krueger Gerald P CBTE Options A - Award D 6,00 6,0000 3.000 18 3.000
2005-01-04 2004-11-05 4 Krueger Gerald P CBTE Options A - Award D 5,80 5,8000 5.000 29 18.000
2005-01-04 2004-11-05 4 Krueger Gerald P CBTE Options A - Award D 5,80 5,8000 5.000 29 13.000
2005-01-04 2004-11-05 4 Krueger Gerald P CBTE Options A - Award D 5,80 5,8000 5.000 29 8.000
2004-09-17 3 Krueger Gerald P CBTE Common Stock D 0
2003-12-01 2003-08-08 4 CAUSEY JAMES D CBTE Options A - Award D 2,42 15.000 15.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista